Publications by authors named "Vinel C"

Glioblastomas are the most common malignant brain tumors in adults; they are highly aggressive and heterogeneous and show a high degree of plasticity. Here, we show that methyltransferase-like 7B (METTL7B) is an essential regulator of lineage specification in glioblastoma, with an impact on both tumor size and invasiveness. Single-cell transcriptomic analysis of these tumors and of cerebral organoids derived from expanded potential stem cells overexpressing METTL7B reveal a regulatory role for the gene in the neural stem cell-to-astrocyte differentiation trajectory.

View Article and Find Full Text PDF

We describe a subset of glioblastoma, the most prevalent malignant adult brain tumour, harbouring a bias towards hypomethylation at defined differentially methylated regions. This epigenetic signature correlates with an enrichment for an astrocytic gene signature, which together with the identification of enriched predicted binding sites of transcription factors known to cause demethylation and to be involved in astrocytic/glial lineage specification, point to a shared ontogeny between these glioblastomas and astroglial progenitors. At functional level, increased invasiveness, at least in part mediated by SRPX2, and macrophage infiltration characterise this subset of glioblastoma.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists are studying how some special processes in brain cell development, called epigenetics, are linked to changes in a type of brain cancer called glioblastoma (GBM).
  • They developed a way to compare cells from glioblastoma with special brain stem cells from patients to find important differences.
  • This research helps identify new ways to treat GBM by finding specific genes that can be targeted with drugs based on each patient's unique cancer.
View Article and Find Full Text PDF
Article Synopsis
  • Glioblastoma (GBM) is a challenging brain tumor with limited treatment options and complex genomic issues that are not fully understood.
  • Researchers conducted a pharmacogenomic analysis of 100 GBM cell cultures, discovering two main subgroups based on their response to certain drugs, notably proteasome inhibitors.
  • The study identifies potential drug combinations that enhance the effectiveness of treatments and offers insights for drug repurposing, aiming to improve future clinical trials and GBM therapies.
View Article and Find Full Text PDF
Article Synopsis
  • Tumour-associated microglia/macrophages (TAM) are the most common types of cells found in brain tumors called glioblastoma multiforme (GBM).
  • A pathway called mTOR, which helps control how cells survive and grow, is more active in these tumors, and researchers are studying how it affects TAM.
  • Their findings suggest that mTOR makes microglia less helpful in fighting the tumor, allowing it to grow and escape the immune system, and they believe targeting mTOR in microglia could be more effective than focusing only on tumor cells.
View Article and Find Full Text PDF

Kidney function is altered by age together with a declined filtration capacity of 5-10% per decade after 35 years. Renal aging shares many characteristics with chronic kidney disease. Plasma levels of the bioactive peptide apelin also decline with age and apelin has been shown to be protective in chronic kidney disease.

View Article and Find Full Text PDF
Article Synopsis
  • Sarcopenia is the age-related decline in muscle mass and strength, and there are currently no effective early diagnostic tools or treatments to prevent it, which often leads to frailty in elderly people.
  • Research shows that the peptide apelin, which is produced during muscle contractions, decreases with age and is linked to the benefits of exercise in older adults.
  • Experiments on mice indicate that restoring apelin signaling can significantly improve muscle function and regenerative abilities, suggesting that apelin could serve as both a diagnostic marker for early sarcopenia and a novel treatment target to combat muscle weakness in aging populations.
View Article and Find Full Text PDF

Introduction: Production of isoprostanes (IsoPs) is enhanced after acute, intense, and prolonged exercise, in untrained subjects. This effect is greater in older subjects. The present study aims to delineate the profile of acute-exercise-induced IsoPs levels in young and older endurance-trained subjects.

View Article and Find Full Text PDF

Aims: Apelin is a recently identified adipokine known to improve glucose tolerance and insulin sensitivity in murine models. This study was dedicated to the proof of concept that apelin administration also enhances insulin sensitivity in humans.

Materials And Methods: Healthy overweight men were enrolled in this randomized, double-blind, placebo-controlled, cross-over study that successively considered the efficacy and the tolerance of 2 doses of (pyr1)-Apelin-13.

View Article and Find Full Text PDF

Ageing is a complex process characterised by a systemic and progressive deterioration of biological functions. As ageing is associated with an increased prevalence of age-related chronic disorders, understanding its underlying molecular mechanisms can pave the way for therapeutic interventions and managing complications. Animal models such as mice are commonly used in ageing research as they have a shorter lifespan in comparison to humans and are also genetically close to humans.

View Article and Find Full Text PDF

Increased incidence of chronic kidney disease (CKD) with consecutive progression to end-stage renal disease represents a significant burden to healthcare systems. Renal tubulointerstitial fibrosis (TIF) is a classical hallmark of CKD and is well correlated with the loss of renal function. The bioactive lysophospholipid lysophosphatidic acid (LPA), acting through specific G-protein-coupled receptors, was previously shown to be involved in TIF development in a mouse model of unilateral ureteral obstruction.

View Article and Find Full Text PDF
Article Synopsis
  • - LEOPARD syndrome, also known as Noonan syndrome with multiple lentigines, is a rare genetic disorder characterized by various developmental issues including heart defects, distinct physical features, short stature, and growth retardation, primarily due to PTPN11 gene mutations.
  • - In a study using a mouse model with a common LS mutation, researchers found that these mice had significantly less body fat and were resistant to obesity, suggesting that the mutation impacts fat storage and energy expenditure.
  • - Preliminary findings from human patients indicate that many affected individuals also have lower body mass index (BMI) and reduced fat, revealing potential metabolic benefits from the disorder while possibly complicating certain aspects of health related to LS.
View Article and Find Full Text PDF

Background: The mechanisms by which the heart adapts to chronic pressure overload, producing compensated hypertrophy and eventually heart failure (HF), are still not well defined. We aimed to investigate the involvement of T cells in the progression to HF using a transverse aortic constriction (TAC) model.

Methods And Results: Chronic HF was associated with accumulation of T lymphocytes and activated/effector CD4(+) T cells within cardiac tissue.

View Article and Find Full Text PDF

Background: It has been suggested that the metabolic benefits of physical exercise could be mediated by myokines. We examined here the effect of exercise training on skeletal muscle expression of a panel of myokines in humans. Pathways regulating myokine expression were investigated in human myotubes.

View Article and Find Full Text PDF

Aims/hypothesis: Lysophosphatidic acid (LPA) is a lipid mediator produced by adipocytes that acts via specific G-protein-coupled receptors; its synthesis is modulated in obesity. We previously reported that reducing adipocyte LPA production in high-fat diet (HFD)-fed obese mice is associated with improved glucose tolerance, suggesting a negative impact of LPA on glucose homeostasis. Here, our aim was to test this hypothesis.

View Article and Find Full Text PDF

Background & Aims: Glucose is absorbed into intestine cells via the sodium glucose transporter 1 (SGLT-1) and glucose transporter 2 (GLUT2); various peptides and hormones control this process. Apelin is a peptide that regulates glucose homeostasis and is produced by proximal digestive cells; we studied whether glucose modulates apelin secretion by enterocytes and the effects of apelin on intestinal glucose absorption.

Methods: We characterized glucose-related luminal apelin secretion in vivo and ex vivo by mass spectroscopy and immunologic techniques.

View Article and Find Full Text PDF